Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Patient Information Leaflet last updated on the eMC: 20/12/2011
PIL Valcyte 450mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 12/08/2011 and displayed until 20/12/2011
Reasons for adding or updating:
  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 17/06/2010 and displayed until 12/08/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 12/05/2006 and displayed until 17/06/2010
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 23/04/2004 and displayed until 12/05/2006
Reasons for adding or updating:
  • Change of manufacturer
Updated on 23/01/2004 and displayed until 23/04/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 02/07/2003 and displayed until 23/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 05/06/2002 and displayed until 02/07/2003
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   valganciclovir hydrochloride